These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9395142)

  • 61. Selection of human anti-HAV McAb from a phage antibody library.
    Wan Z; Wang H; Jiang S
    Chin J Biotechnol; 1998; 14(3):173-8. PubMed ID: 10503077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis A vaccines.
    Wkly Epidemiol Rec; 2000 Feb; 75(5):38-44. PubMed ID: 10693358
    [No Abstract]   [Full Text] [Related]  

  • 63. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate?
    Prohaska W; Wolff C; Lechler E; Kleesiek K
    Klin Wochenschr; 1991 May; 69(7):294-6. PubMed ID: 1712414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of total antibody against hepatitis A virus by an automated microparticle enzyme immunoassay.
    Robbins DJ; Krater J; Kiang W; Alcalde X; Helgesen S; Carlos J; Mimms L
    J Virol Methods; 1991 May; 32(2-3):255-63. PubMed ID: 1651952
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapid and efficient purification of hepatitis A virus from cell culture.
    Bishop NE; Hugo DL; Borovec SV; Anderson DA
    J Virol Methods; 1994 Apr; 47(1-2):203-16. PubMed ID: 8051227
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection.
    Gómara MJ; Riedemann S; Vega I; Ibarra H; Ercilla G; Haro I
    J Immunol Methods; 2000 Feb; 234(1-2):23-34. PubMed ID: 10669766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodies.
    Claeys H; Volckaerts A; De Beenhouwer H; Vermylen C
    J Med Virol; 1992 Apr; 36(4):259-64. PubMed ID: 1315838
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells.
    Wheeler CM; Fields HA; Schable CA; Meinke WJ; Maynard JE
    J Clin Microbiol; 1986 Mar; 23(3):434-40. PubMed ID: 3007565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.
    Arístegui J; Morales JL; Dal-Ré R; González A; Gallego MS; Garrote E
    Infection; 1995; 23(5):334-8. PubMed ID: 8557400
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enzyme immunoassay for antibodies to membrane associated antigen of varicella zoster virus.
    Cox JC; Moloney MB; Herrington RW; Hampson AW; Hurrell JG
    J Virol Methods; 1984 Feb; 8(1-2):137-45. PubMed ID: 6323506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Shifting seroepidemiology of hepatitis A in Japan, 1973-2003.
    Kiyohara T; Sato T; Totsuka A; Miyamura T; Ito T; Yoneyama T
    Microbiol Immunol; 2007; 51(2):185-91. PubMed ID: 17310086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exposure to enteroviruses and hepatitis A virus among divers in environmental waters in France, first biological and serological survey of a controlled cohort.
    Garin D; Fuchs F; Crance JM; Rouby Y; Chapalain JC; Lamarque D; Gounot AM; Aymard M
    Epidemiol Infect; 1994 Dec; 113(3):541-9. PubMed ID: 7995363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.
    Lemon SM; Binn LN
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2501-5. PubMed ID: 2997380
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Propagation and assay of hepatitis A virus in vitro.
    Siegl G; deChastonay J; Kronauer G
    J Virol Methods; 1984 Aug; 9(1):53-67. PubMed ID: 6094609
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of labelled antibody methods for the detection of virus antigens in cell monolayers.
    Oram JD; Crooks AJ
    J Immunol Methods; 1979; 25(4):297-310. PubMed ID: 372444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.
    Yu C; Engle RE; Bryan JP; Emerson SU; Purcell RH
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):579-86. PubMed ID: 12853389
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccine.
    Laufer DS; Hurni W; Watson B; Miller W; Ryan J; Nalin D; Brown L
    Clin Infect Dis; 1995 Apr; 20(4):868-71. PubMed ID: 7795087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.